Harvey Capital Management Inc
Source: SEC Form 13F · as of Mar 2026Harvey Capital Management Inc holds 11 biotech & pharma companies tracked by BioSniper, totaling $39.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$39.1M
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 9,976 | $7.7M |
| JAZZJazz Pharmaceuticals plc | 35,320 | $6.7M |
| LLYELI LILLY & Co | 6,373 | $5.9M |
| HALOHALOZYME THERAPEUTICS, INC. | 90,600 | $5.9M |
| BBIOBridgeBio Pharma, Inc. | 57,285 | $4.3M |
| ARGXARGENX SE | 4,501 | $3.3M |
| CYTKCYTOKINETICS INC | 49,295 | $3.2M |
| JNJJOHNSON & JOHNSON | 5,000 | $1.2M |
| ABVXAbivax SA | 4,300 | $479K |
| MRKMerck & Co., Inc. | 2,500 | $301K |
| ZTSZoetis Inc. | 2,000 | $236K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.